Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › PathSensors Gets Expanded License to MIT Pathogen Detection Technology

PathSensors Gets Expanded License to MIT Pathogen Detection Technology

Jul 09, 2020
|
staff reporter

NEW YORK — PathSensors said on Thursday that it has signed an agreement expanding its exclusive license to a Massachusetts Institute of Technology-developed pathogen detection technology to include clinical applications.

According to the Baltimore-based company, its first clinical application of the technology will be for SARS-CoV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Infectious Disease

  1. Lab Stakeholders Welcome Biden Moves on COVID-19 Testing, Suggest Additional Steps

    Premium

  2. FIND, Unitaid Ink First Agreement to Enable COVID-19 Antigen Tests at $2.50 Apiece

  3. Rhinostics Licenses Procter & Gamble Nasal Swab for COVID-19 Testing

  4. Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

  5. SureScreen Dx Antigen Test Moves to Forefront of UK Effort to Control Spread of COVID-19

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.